Custom crystal commemorating the submission of a New Drug Application (NDA) to the FDA. The application for Impel NeuroPharma’s migraine treatment INP104 was supported by a Phase 3, open-label safety and tolerability trial. (20ALJ356)
Custom crystal commemorating the submission of a New Drug Application (NDA) to the FDA. The application for Impel NeuroPharma’s migraine treatment INP104 was supported by a Phase 3, open-label safety and tolerability trial. (20ALJ356)
"*" indicates required fields
Lucite Embedments: What Works and What Doesn't? Lucite embedments can have extraordinary appeal and perceived value among recipients. The piece shown above is a great example. It's not hard to imagine how a commemorative recognizing the...
Logo-themed designs tend to be a frequent suggestion for custom corporate awards. After all, the perceived value and cachet of custom awards lies in their distinctive design elements. And logos, because they are by definition distinctive, offer a...
Coming up with unique award and gift ideas for the oil industry can be a challenge. Many of the traditional concepts may seem tired and unlikely to have considerable perceived value. These include, for instance, the many variations of brass pump...